Beam Therapeutics BEAM Enterprise value

Enterprise value at other companies

Vertex PharmaceuticalsVRTX

$120.2B+7.2%

Arrowhead ResearchARWR

$8.7B+418%

Ultragenyx PharmaceuticalRARE

$1.83B-51.1%

MGN

MagniteMGNI

$2.81B-13.2%

Wave Life SciencesWVE

$793.44M-9.4%

Intellia TherapeuticsNTLA

$2.33B+149%

FAQ

What is Beam Therapeutics's enterprise value?

Beam Therapeutics (BEAM) reported enterprise value of $2.39B in Q1 2026.

How has Beam Therapeutics's enterprise value changed year-over-year?

Beam Therapeutics's enterprise value increased by 51.2% year-over-year, from $1.58B to $2.39B.

What is the long-term trend for Beam Therapeutics's enterprise value?

Over 5 years (2020 to 2025), Beam Therapeutics's enterprise value has grown at a -13.5% compound annual growth rate (CAGR), from $5.51B to $2.67B.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.